Open AccessObesity and chronic kidney disease progression—the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1
Author(s) -
Diego Barbieri,
Marián Goicoechea,
María Dolores Sánchez-Niño,
Alberto Ortíz,
Eduardo Verde,
Úrsula Verdalles,
Ana Pérez de José,
Andrés Delgado,
Esther Hurtado,
Luis Sánchez-Cámara,
Nieves López Lazareno,
Ana GarcíaPrieto,
José Luño
Publication year - 2018
Publication title -
clinical kidney journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 40
eISSN - 2048-8513
pISSN - 2048-8505
DOI - 10.1093/ckj/sfy095
Subject(s) - medicine , renal function , kidney disease , body mass index , diabetes mellitus , creatinine , endocrinology , blood pressure , albuminuria , uric acid , population , interquartile range , adipokine , hyperuricemia , obesity , gastroenterology , insulin resistance , environmental health
CTRP1 levels are higher in obese than in non-obese patients with CKD. High CTRP1 levels may have a renal protective role since they were associated with slower kidney disease progression. Interventional studies are needed to explore this hypothesis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom